Letter to the Editor
Development of factor VIII inhibitors in two patients with moderate haemophilia A
Correspondence: Rita Paschal, MD, Division of Hematology/Oncology, 2220 Pierce Avenue, 777 Preston Research Building, Nashville, TN 37232-6307, USA.
Tel.: 615 322 4967; fax: 615 3437602;
No abstract is available for this article.